Metallodrugs in cancer nanomedicine

Cites (441)

Items 201–400 of 441

1. The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
   Nicholas C. Lloyd, Hugh W. Morgan, Brian K. Nicholson · 2004 · Angewandte Chemie International Edition
2. Targeting iron metabolism in cancer therapy
   Michael Morales, Xiang Xue · 2021 · Theranostics
3. Renal Clearable Ultrasmall Single-Crystal Fe Nanoparticles for Highly Selective and Effective Ferroptosis Therapy and Immunotherapy
   Huan Liang, Xiyao Wu, Guizhen Zhao, Kai Feng, Kaiyuan Ni, Xiaolian Sun · 2021 · Journal of the American Chemical Society
4. Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery
   Anna K. Renfrew · 2014 · Metallomics
5. Drug Delivery Strategies for Platinum-Based Chemotherapy
   Richard J. Browning, Philip James Thomas Reardon, Maryam Parhizkar, R. Barbara Pedley, Mohan J. Edirisinghe, Jonathan Campbell Knowles, Eleanor Stride · 2017 · ACS Nano
6. Oxaliplatin
   Joanne Graham, Mohamed Muhsin, Peter N. Kirkpatrick · 2004 · Nature Reviews Drug Discovery
7. Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial
   Katherine M.W. Pisters, Eric Vallières, John J. Crowley, Wilbur A. Franklin, Paul A. Bunn, Robert J. Ginsberg, Joe Bill Putnam, Kari Chansky, David R. Gandara · 2010 · Journal of Clinical Oncology
8. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles
   Peter C. Dedon, Richard F. Borch · 1987 · Biochemical Pharmacology
9. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
   Géraldine Gentric, Virginie Mieulet, Fatima Mechta‐Grigoriou · 2016 · Antioxidants and Redox Signaling
10. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers
    Éric Raymond, Christine Buquet-Fagot, Siham Djelloul, Ján Mešter, Esteban Cvitkovic, P Allain, Christophe Louvet, Christian P. Gespach · 1997 · Anti-Cancer Drugs
11. Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities
    Aviva Levina, Debbie C. Crans, Peter A. Lay · 2017 · Coordination Chemistry Reviews
12. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
    Susanna B. Park, Cindy S.-Y. Lin, Arun V. Krishnan, David Goldstein, Michael Leonard Friedlander, Matthew C. Kiernan · 2009 · Brain
13. Cancer nanomedicine: is targeting our target?
    Twan Lammers, Fabian M. Kiessling, Marianne B. Ashford, Wim E. Hennink, Daan J.A. Crommelin, Gert Storm · 2016 · Nature Reviews Materials
14. A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
    Johannes Karges, Thirumal Yempala, Mickaël Tharaud, Dan Gibson, Gilles Gasser · 2020 · Angewandte Chemie International Edition
15. Designing nanomedicine for immuno-oncology
    Wen Jiang, Christina A. Von Roemeling, Yuanxin Chen, Yaqing Qie, Xiujie Liu, Jianzhu Chen, Betty Y.S. Kim · 2017 · Nature Biomedical Engineering
16. Lipoplatin Formulation Review Article
    Stathopoulos, G. P., Boulikas, T. · 2012 · Journal of Drug Delivery
17. Heparin‐Engineered Mesoporous Iron Metal‐Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers
    Elena Bellido, Tania Hidalgo, M.V. Lozano, Mazheva Guillevic, Rosana Simón‐Vázquez, Manuel Jesús Santander-Ortega, África González‐Fernández, Christian Serre, Marı́a José Alonso, Patricia Horcajada · 2015 · Advanced Healthcare Materials
18. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.
    Du-Xin Sun, S. Zhou, Wei Gao · 2020 · ACS Nano
19. IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel as 1L therapy in advanced squamous NSCLC.
    Robert M. Jotte, Federico Cappuzzo, Ihor O. Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez‐Abreu, Maen Hussein, Ross Andrew Soo, Henry Jacob Conter, Toshiyuki Kozuki, Carlos Alberto da Silva et al. · 2018 · Journal of Clinical Oncology
20. Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs
    Waseem A. Wani, Sanjiv Prashar, Sheikh Shreaz, Santiago Gómez‐Ruiz · 2016 · Coordination Chemistry Reviews
21. 7. MEDICINAL CHEMISTRY OF GOLD ANTICANCER METALLODRUGS
    Angela Casini, Raymond Wai‐Yin Sun, Ingo Ott · 2018 · De Gruyter eBooks
22. A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors
    Jeany M. Rademaker-Lakhai, C. Terret, Stephen B. Howell, C. Baud, Richard F. de Boer, Dick Pluim, Jos H. Beijnen, Jan H.M. Schellens, Jean‐Pierre Droz · 2004 · Clinical Cancer Research
23. Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
    Xiang Ling, Xing Chen, Imogen A. Riddell, Wei Tao, Junqing Wang, Geoffrey Hollett, Stephen J. Lippard, Omid Cameron Farokhzad, Jinjun Shi, Jun Wu · 2018 · Nano Letters
24. Modern Supramolecular Gold Chemistry
    2008 · Wiley eBooks
25. In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein crosslinking, and inhibition of replication
    Richard B. Ciccarelli, Mark J. Solomon, Alexander J. Varshavsky · 1985 · Biochemistry
26. Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5‑Fluorouracil for Colorectal Cancer and Liver Metastasis
    Jianfeng Guo, Zhuo Yu, Manisit Das, Leaf Huang · 2020 · ACS Nano
27. Metallic nanoparticles as drug delivery system for the treatment of cancer
    Neha Desai, Munira M. Momin, Tabassum Asif Khan, Sankalp Gharat, Raghumani Singh Ningthoujam, Abdelwahab Omri · 2021 · Expert Opinion on Drug Delivery
28. Inorganic Chemistry and Drug Design
    Peter John Sadler · 1991 · Advances in inorganic chemistry
29. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473
    J Holford, Swee Y. Sharp, Barry A. Murrer, M Abrams, Lloyd R. Kèlland · 1998 · British Journal of Cancer
30. Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?
    Angela Casini, Jan Reedijk · 2012 · Chemical Science
31. Long-term delivery of protein therapeutics
    Ravi D. Vaishya, Varun Khurana, Sulabh P. Patel, Ashim K. Mitra · 2014 · Expert Opinion on Drug Delivery
32. The chemistry of the gold drugs used in the treatment of rheumatoid arthritis
    Douglas H. Brown, W. Ewen Smith · 1980 · Chemical Society Reviews
33. Personalized Nanomedicine
    Twan Lammers, Larissa Yokota Rizzo, Gert Storm, Fabian M. Kiessling · 2012 · Clinical Cancer Research
34. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
    Shuofeng Yuan, Runming Wang, Jasper Fuk‐Woo Chan, Jinxia Zhang, Tianfan Cheng, Kenn Ka‐Heng Chik, Zi‐Wei Ye, Suyu Wang, Andrew Chak-Yiu Lee, Lijian Jin et al. · 2020 · Nature Microbiology
35. Pt( iv ) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate
    Jenny Zhang, Ezequiel Wexselblatt, Trevor W. Hambley, Dan Gibson · 2011 · Chemical Communications
36. Metal–Organic Framework Nanoparticles Induce Pyroptosis in Cells Controlled by the Extracellular pH
    Evelyn Ploetz, Andreas Zimpel, Valentina Cauda, David Bauer, Don C. Lamb, Christoph Haisch, Stefan Zahler, Angelika M. Vollmar, Stefan Wuttke, Hanna Engelke · 2020 · Advanced Materials
37. Introduction to Coordination Chemistry
    Geoffrey A. Lawrance · 2009 · Wiley eBooks
38. Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors
    Sabine van Rijt, Deniz A. Bölükbas, Christian Argyo, Stefan Datz, Michael Lindner, Oliver Eickelberg, Mélanie Königshoff, Thomas Bein, Silke Meiners · 2015 · ACS Nano
39. On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
    Andreas Meyer, Christoph P. Bagowski, Malte Kokoschka · 2012 · Angewandte Chemie International Edition
40. Phorbiplatin, a Highly Potent Pt(IV) Antitumor Prodrug That Can Be Controllably Activated by Red Light
    Zhigang Wang, Na Wang, Shun‐Cheung Cheng, Kai Xu, Zhiqin Deng, Shu Chen, Zoufeng Xu, Kai Xie, Man‐Kit Tse, Peng Shi et al. · 2019 · Chem
41. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: Implications for anticancer therapeutics targeted to mitochondria
    Oliver Rackham, Scott J. Nichols, Peter J. Leedman, Susan J. Berners‐Price, Aleksandra Filipovska · 2007 · Biochemical Pharmacology
42. Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance
    Yongheng Wang, Yuhang Jiang, Dengshuai Wei, Priya Singh, Yingjie Yu, Teresa Lee, Lingpu Zhang, Hanna K. Mandl, Alexandra S. Piotrowski-Daspit, Xinyuan Chen et al. · 2021 · Nature Biomedical Engineering
43. Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
    Kevin Joseph Harrington, C.R. Lewanski, A.D. Northcote · 2001 · Annals of Oncology
44. Pt(IV) complexes as prodrugs for cisplatin
    Yi Shi, Shu-An Liu, Deborah J. Kerwood · 2011 · Journal of Inorganic Biochemistry
45. PSMA Theranostics: Current Status and Future Directions
    Kambiz Rahbar, Ali Afshar‐Oromieh, Hossein Jadvar, Hojjat Ahmadzadehfar · 2018 · Molecular Imaging
46. Multi-action Pt(IV) anticancer agents; do we understand how they work?
    Dan Gibson · 2018 · Journal of Inorganic Biochemistry
47. Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
    Zoufeng Xu, Zhigang Wang, Zhiqin Deng, Guangyu Zhu · 2021 · Coordination Chemistry Reviews
48. Gold in medicine
    Gregory J. Higby · 1982 · Gold bulletin
49. Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells
    Paul A. Andrews, Dr Michael Murphy, StephenB. Howell · 1987 · Cancer Chemotherapy and Pharmacology
50. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
    Hsi-Hsien Hsu, Ming‐Cheng Chen, Rathinasamy Baskaran, Yueh‐Min Lin, Cecilia Hsuan Day, Yi‐Jiun Lin, Chuan‐Chou Tu, V. Vijaya Padma, Wei‐Wen Kuo, Chih‐Yang Huang · 2017 · Journal of Cellular Physiology
51. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements
    Tanios S Bekaii-Saab, Juan W. Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Mercade Macarulla, John A. Bridgewater, Harpreet Singh Wasan et al. · 2020 · Future Oncology
52. Clinical application of polymeric micelles for the treatment of cancer
    Aida Varela-Moreira, Yang Shi, Marcel H.A.M. Fens, Twan Lammers, Wim E. Hennink, Raymond Michel Schiffelers · 2017 · Materials Chemistry Frontiers
53. ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
    David P. Nowotnik, Esteban Cvitkovic · 2009 · Advanced Drug Delivery Reviews
54. pH-Triggered Charge-Reversal Polypeptide Nanoparticles for Cisplatin Delivery: Preparation and In Vitro Evaluation
    Yue Huang, Zhaohui Tang, Xuefei Zhang · 2013 · Biomacromolecules
55. Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?
    Reece G. Kenny, Su Wen Chuah, Alanna Crawford, Celine J. Marmion · 2016 · European Journal of Inorganic Chemistry
56. Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
    Ke Lin, Zizhuo Zhao, Huaben Bo, Xiaojuan Hao, Jinquan Wang · 2018 · Frontiers in Pharmacology
57. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
    William C. Zamboni, Anne C. Gervais, Merrill J. Egorin, Jan H.M. Schellens, Eleanor G. Zuhowski, Dick Pluim, Erin Joseph, Deborah R. Hamburger, Peter K. Working, Gail T. Colbern et al. · 2004 · Cancer Chemotherapy and Pharmacology
58. Recent advances in iron complexes as potential anticancer agents
    Waseem A. Wani, Umair Baig, Sheikh Shreaz, Rayees Ahmad Shiekh, Prince Firdous Iqbal, Ehtesham Jameel, Akil Ahmad, Siti Hamidah Mohd‐Setapar, Md. Mushtaque, Lee Ting Hun · 2015 · New Journal of Chemistry
59. Radiation Improves the Distribution and Uptake of Liposomal Doxorubicin (Caelyx) in Human Osteosarcoma Xenografts
    Catharina de Lange Davies, Lisa M. Lundstrøm, Jomar Frengen, Live Eikenes, Øyvind Sverre Bruland, Olav Kaalhus, Mari H. B. Hjelstuen, Christian Brekken · 2004 · Cancer Research
60. π-Extended Benzoporphyrin-Based Metal–Organic Framework for Inhibition of Tumor Metastasis
    Jin‐Yue Zeng, Mei‐Zhen Zou, Mingkang Zhang, Xiaoshuang Wang, Xuan Zeng, Hengjiang Cong, Xian‐Zheng Zhang · 2018 · ACS Nano
61. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
    Catherine Lherm, Rainer Helmut Müller, Francis Puisieux, Patrick Couvreur · 1992 · International Journal of Pharmaceutics
62. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action
    Yingyan Xue, Song Gao, Jingxin Gou, Tian Yin, Haibing He, Yanjiao Wang, Yu Xin Zhang, Xing Tang, Rong Wu · 2020 · Expert Opinion on Drug Delivery
63. The beginning of the end of the nanomedicine hype
    Kinam Park · 2019 · Journal of Controlled Release
64. Liposomes: Versatile and Biocompatible Nanovesicles for Efficient Biomolecules Delivery
    Sudipta Mallick, Joon Sig Choi · 2014 · Journal of Nanoscience and Nanotechnology
65. Triple action Pt( iv ) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance
    Emanuele Petruzzella, Roman Sirota, Irene Solazzo, Valentina Gandin, Dan Gibson · 2018 · Chemical Science
66. Therapeutic Targeting of ATP7B in Ovarian Carcinoma
    Lingegowda Selanere Mangala, Vesna Zuzel, Rosemarie E. Schmandt, Erik S LeShane, Jyotsna B. Halder, Guillermo N. Armaiz-Peña, Whitney A. Spannuth, Takemi Tanaka, Mian M.K. Shahzad, Yvonne Gail Lin et al. · 2009 · Clinical Cancer Research
67. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione
    Alan R. Eastman, Michael A. Barry · 1987 · Biochemistry
68. Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer
    S C White, Paul C. Lorigan, Geoffrey P. Margison · 2006 · British Journal of Cancer
69. 64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
    Rodney John Hicks, Price A Jackson, Grace Kong et al. · 2018 · Journal of Nuclear Medicine
70. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity
    Ying Xu, Xuexiang Han, Yiye Li, Huan Min, Xiao Zhao, Yinlong Zhang, Yingqiu Qi, Jian Ying Shi, Sheng Qi, Yongping Bao et al. · 2019 · ACS Nano
71. Emerging platinum( iv ) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
    Zhigang Wang, Zhiqin Deng, Guangyu Zhu · 2019 · Dalton Transactions
72. Antitumor Titanium Compounds
    M. Rossi · 2004 · Mini-Reviews in Medicinal Chemistry
73. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
    Stefano Chong Hun Kim, Éric François, Thierry André et al. · 2018 · The Lancet Oncology
74. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles
    Shanthi Ganesh, Arun K. Iyer, Florence Gattacceca, David V. Morrissey, Mansoor M. Amiji · 2013 · Journal of Controlled Release
75. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer
    Tomislav Dragovich, David S. Mendelson, Sandra E Kurtin, Kelly Richardson, Daniel D. Von Hoff, Axel Hoos · 2006 · Cancer Chemotherapy and Pharmacology
76. Nucleus‐Targeted Organoiridium–Albumin Conjugate for Photodynamic Cancer Therapy
    Ping-Yu Zhang, Huai-Yi Huang, Samya Banerjee, G. Clarkson, Chen Ge, Cinzia Imberti, P. Sadler · 2018 · Angewandte Chemie
77. Sustained codelivery of cisplatin and paclitaxel via an injectable prodrug hydrogel for ovarian cancer treatment
    Shen, Wenjia, Chen, Xiaobin, Luan, Jiabin, Wang, Danni, Yu, Lin, Ding, Jiandong · 2017 · ACS Applied Materials & Interfaces
78. The Chelate, Cryptate and Macrocyclic Effects
    Robert D. Hancock, Arthur E. Martell · 1988 · Comments on Inorganic Chemistry
79. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
    Jianliang Shen, Han-Cheon Kim, Joy Wolfram, Chaofeng Mu, Wei Zhang, Haoran Liu, Yan Xie, Junhua Mai, Hang Zhang, Zhi Li et al. · 2017 · Nano Letters
80. Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment
    John D. Martin, Myrofora Panagi, Chenyu Wang, Thahomina Khan, Margaret R. Martin, Chrysovalantis Voutouri, Kazuko Toh, Panagiotis Papageorgis, Fotios Mpekris, Christiana Polydorou et al. · 2019 · ACS Nano
81. Docetaxel Versus Docetaxel Plus Cisplatin As Front-Line Treatment of Patients With Advanced Non—Small-Cell Lung Cancer: A Randomized, Multicenter Phase III Trial
    Vassilis Georgoulias, Alexandros S Ardavanis, Athina Agelidou, Maria Agelidou, Vassilis Chandrinos, Emilia Tsaroucha, Michael Toumbis, Charalambos Kouroussis, Konstantinos Syrigos, Aristidis Polyzos et al. · 2004 · Journal of Clinical Oncology
82. NIR-II light-modulated thermosensitive hydrogel for light-triggered cisplatin release and repeatable chemo-photothermal therapy
    Changping Ruan, Chanjuan Liu, Hailu Hu, Xiaolu Guo, Bang‐Ping Jiang, Hong Liang, Xing‐Can Shen · 2019 · Chemical Science
83. Facile Preparation of Mono‐, Di‐ and Mixed‐Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
    Jenny Zhang, Paul Bonnitcha, Ezequiel Wexselblatt, Alice V. Klein, Yousef Najajreh, Dan Gibson, Trevor W. Hambley · 2012 · Chemistry - A European Journal
84. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
    Twan Lammers, Vladimír Šubr, Peter Peschke, Rainer Kühnlein, Wim E. Hennink, Karel Ulbrich, Fabian M. Kiessling, M. Heilmann, Jürgen Debus, Peter Ernst Huber et al. · 2008 · British Journal of Cancer
85. Lithium Reduces Pathological Aggression and Suicidality: A Mini-Review
    Bruno Müller-Oerlinghausen, Ute Lewitzka · 2010 · Neuropsychobiology
86. Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial
    George P. Stathopoulos, Dimosthenis Antoniou, J. Dimitroulis, Pinelopi Michalopoulou, Antonios Bastas, Kostas Marosis, J. Stathopoulos, Aspasia Provata, P. Yiamboudakis, Dimitrios Veldekis et al. · 2010 · Annals of Oncology
87. Platinum nanoparticles: a non-toxic, effective and thermally stable alternative plasmonic material for cancer therapy and bioengineering
    Akbar Samadi, Henrik Klingberg, Liselotte Jauffred · 2018 · Nanoscale
88. A Cisplatin‐Loaded Immunochemotherapeutic Nanohybrid Bearing Immune Checkpoint Inhibitors for Enhanced Cervical Cancer Therapy
    Na Wang, Zhigang Wang, Zoufeng Xu, Xianfeng Chen, Guangyu Zhu · 2018 · Angewandte Chemie International Edition
89. A Quadruple‐Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines
    Emanuele Petruzzella, Jeremy Phillip Braude, Janice Rae Aldrich-Wright, Valentina Gandin, Dan Gibson · 2017 · Angewandte Chemie International Edition
90. OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
    Vassiliki A. Papadimitrakopoulou, Manuel Cobo, Rodolfo Eduardo Bordoni et al. · 2018 · Journal of Thoracic Oncology
91. Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug Release
    Haimei Chen, Robert C. MacDonald, Shuyou Li · 2006 · Journal of the American Chemical Society
92. Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus gemcitabine in patients with advanced solid tumors
    Subbiah, Vivek, Grilley-Olson, Juneko E., Combest, Austin J., Sharma, Neelesh, Tran, Richard H., Bobe, Iulian, Osada, Atsushi, Takahashi, Kazuhiro, Balkissoon, Jaikrishna, Camp, Aaron et al. · 2018 · Clinical Cancer Research
93. Poly(amidoamine) Dendrimer-Coordinated Copper(II) Complexes as a Theranostic Nanoplatform for the Radiotherapy-Enhanced Magnetic Resonance Imaging and Chemotherapy of Tumors and Tumor Metastasis
    Yu Fan, Jiulong Zhang, Menghan Shi, Dan Li, Chunhua Lü, Xueyan Cao, Chen Peng, Serge M. Mignani, Jean‐Pierre Majoral, Xiangyang Shi · 2019 · Nano Letters
94. Decoration of Cisplatin on 2D Metal–Organic Frameworks for Enhanced Anticancer Effects through Highly Increased Reactive Oxygen Species Generation
    Yao‐Jia Li, Zhiguo Gao, Fanghui Chen et al. · 2018 · ACS Applied Materials & Interfaces
95. Pharmacokinetics of Oxaliplatin in Humans
    Hans Ehrsson, Inger Wallin, Jeffrey Yachnin · 2002 · Medical Oncology
96. Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona
    Ayan Kumar Barui, Jun Yong Oh, Batakrishna Jana, Chaekyu Kim, Ja‐Hyoung Ryu · 2019 · Advanced Therapeutics
97. Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
    Azadeh Kheirolomoom, Lisa M. Mahakian, Chun-Yen Lai, Heather A. Lindfors, Jai Woong Seo, Eric E. Paoli, Katherine D. Watson, Eric M. Haynam, Elizabeth S. Ingham, Xing Li et al. · 2010 · Molecular Pharmaceutics
98. Understanding the Burst Release Phenomenon: Toward Designing Effective Nanoparticulate Drug-Delivery Systems
    Sourav Bhattacharjee · 2020 · Therapeutic Delivery
99. The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
    Jean Paul Guastalla, Veronique C Dieras · 2003 · British Journal of Cancer
100. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy
     Qian Yang, Jinrong Peng, Kun Shi, Yao Xiao, Qingya Liu, Ruxia Han, Xiawei Wei, Zhiyong Qian · 2019 · Journal of Controlled Release
101. Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity
     Maria V. Babak, Zhi Hua Yang, Bertrand Czarny · 2019 · Angewandte Chemie International Edition
102. Structural Investigation of Cisplatin–Protein Interactions: Selective Platination of His19 in a Cuprozinc Superoxide Dismutase
     V. Calderone, Angela Casini, Stefano Mangani · 2006 · Angewandte Chemie International Edition
103. The success of nanomedicine
     Twan Lammers, Mauro Ferrari B · 2020 · Nano Today
104. Microneedles loaded with anti-PD-1–cisplatin nanoparticles for synergistic cancer immuno-chemotherapy
     Xinmiao Lan, Wang‐Yong Zhu, Xinshuo Huang, Yingjie Yu, Haihua Xiao, Lijian Jin, Jingya Jane Pu, Xi Xie, Juncong She, Vivian Wai Yan Lui et al. · 2020 · Nanoscale
105. Oxaliplatin in practice
     J-L Misset · 1998 · British Journal of Cancer
106. Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agent
     Xin Zeng, Jie Sun, Suping Li et al. · 2020 · Nature Communications
107. Original Multivalent Copper(II)-Conjugated Phosphorus Dendrimers and Corresponding Mononuclear Copper(II) Complexes with Antitumoral Activities
     Nabil El Brahmi, Saı̈d El Kazzouli, Serge M. Mignani, El Mokhtar Essassi, Geneviève Aubert, Régis Laurent, Anne‐Marie Caminade, Mosto Bousmina, Thierry Cresteil, Jean‐Pierre Majoral · 2013 · Molecular Pharmaceutics
108. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
     Yu Han, Wei Yin, Junjie Li, Hong Liang Zhao, Zengshi Zha, Wendong Ke, Yuheng Wang, Chuanxin He, Zhishen Ge · 2018 · Journal of Controlled Release
109. The Trans Effect in Metal Complexes
     Fred Basolo, Ralph G. Pearson · 1962 · Progress in inorganic chemistry
110. Effects of Drug Hydrophobicity on Liposomal Stability
     David R. Khan, Evonne M. Rezler, Janelle L. Lauer‐Fields, Gregg B. Fields · 2007 · Chemical Biology & Drug Design
111. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity
     Ki Hyun Bae, Susi Tan, Atsushi Yamashita, Wei Xia Ang, Shu Jun Gao, Shu Wang, Joo Eun Chung, Motoichi Kurisawa · 2017 · Biomaterials
112. Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far
     Sandra Jesus, Mélanie Schmutz, Claudia Som, Gerrit Borchard, Peter Wick, Olga Borges · 2019 · Frontiers in Bioengineering and Biotechnology
113. Recent advances in the chemistry of iron-based chemotherapeutic agents
     Uttara Basu, Mithun Roy, Akhil Ranjan Chakravarty · 2020 · Coordination Chemistry Reviews
114. Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum( iv ) prodrug with unique mode of action
     Lili Ma, Rong Ma, Yi‐Ping Wang, Xiaoyue Aelita Zhu, Junliang Zhang, Hoi Ching Chan, Xianfeng Chen, Wenjun Zhang, Sung-Kay Chiu, Guangyu Zhu · 2015 · Chemical Communications
115. Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review
     Denis L. Fontes Jardim, Eric S. Groves, Philip P. Breitfeld, Razelle Kurzrock · 2016 · Cancer Treatment Reviews
116. Clinical Trials of Thermosensitive Nanomaterials: An Overview
     Stefania Nardecchia, Paola Sánchez‐Moreno, Juan de Vicente, Juan Antonio Marchal, Houría Boulaiz · 2019 · Nanomaterials
117. Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives
     Yang Shi · 2020 · Advanced Therapeutics
118. Paul Ehrlich: founder of chemotherapy
     Stefan H. E. Kaufmann · 2008 · Nature Reviews Drug Discovery
119. Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase
     Zuandi Luo, Lianling Yu, Fang Yang, Zhennan Zhao, Bo Yu, Haoqiang Lai, Ka‐Hing Wong, Sai Ming Ngai, Wenjie Zheng, Tianfeng Chen · 2014 · Metallomics
120. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines
     Scott Edmonds, Alessia Volpe, Hilary Shmeeda, Ana C. Parente‐Pereira, Riya Radia, Júlia Baguña Torres, Istvan Szanda, Gregory W. Severin, Lefteris Livieratos, Philip J. Blower et al. · 2016 · ACS Nano
121. Lessons Learned from Two Decades of Anticancer Drugs
     Zhichao Liu, Brian Delavan, Ruth Angela Roberts, Weida Tong · 2017 · Trends in Pharmacological Sciences
122. Selective anticancer copper( ii )-mixed ligand complexes: targeting of ROS and proteasomes
     Chew Hee Ng, Siew Ming Kong, Yee Lian Tiong, Mohd Jamil Maah, Nurhazwani Sukram, Munirah Ahmad, Alan Soo Beng Khoo · 2014 · Metallomics
123. Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin
     Yi Shi, Jerry Goodisman, James C. Dabrowiak · 2013 · Inorganic Chemistry
124. Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
     John Randall Eckardt, Dmitry Bentsion, Oleg Nikolaevich Lipatov, Igor S. Polyakov, F. Roy MacKintosh, David Alan Karlin, Gizelle S. Baker, Hazel B. Breitz · 2009 · Journal of Clinical Oncology
125. Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis
     Lina Xie, Zuandi Luo, Zhennan Zhao, Tianfeng Chen · 2016 · Journal of Medicinal Chemistry
126. Targeted therapy of spontaneous murine pancreatic tumors by polymeric micelles prolongs survival and prevents peritoneal metastasis
     Horacio Cabral, Mami Murakami, Hironori Hojo, Yasuko Terada, Mitsunobu R. Kano, Ung‐il Chung, Nobuhiro Nishiyama, Kazunori Kataoka · 2013 · Proceedings of the National Academy of Sciences
127. Oxaliplatin: a review of approved uses
     Alexander Stein, Dirk Arnold · 2011 · Expert Opinion on Pharmacotherapy
128. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
     Zhongyun Dong, Yin Liu, Kieran F. Scott, Linda Levin, Krishnanath Gaitonde, R. Bruce Bracken, Barbara Morales Burke, Qihui “Jim” Zhai, Jiang Wang, Leslie Oleksowicz et al. · 2010 · Carcinogenesis
129. Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins
     Silvia Alonso‐de Castro, Aitziber L. Cortajarena, Fernando López‐Gallego · 2018 · Angewandte Chemie International Edition
130. Platinum(iv) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversal
     Jian Li, Siew Qi Yap, Chee Fei Chin · 2012 · Chemical Science
131. Copper-Gallic Acid Nanoscale Metal–Organic Framework for Combined Drug Delivery and Photodynamic Therapy
     Shalini Sharma, Disha Mittal, Anita Kamra Verma · 2019 · ACS Applied Bio Materials
132. Peptide‐Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells
     Michal S. Shoshan, Thomas Vonderach, Bodo Hattendorf, Helma Wennemers · 2018 · Angewandte Chemie International Edition
133. Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
     Dorien M. Schrijvers, C. van Herpen, Joseph N. Kerger et al. · 2004 · Annals of Oncology
134. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
     Kathleen N. Moore, Thomas J. Herzog, Sharyn Nan Lewin, Robert Lawrence Giuntoli, Deborah Kay Armstrong, Rodney Paul Rocconi, Whitney A. Spannuth, Michael A. Gold · 2007 · Gynecologic Oncology
135. A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
     Kamalesh Kumar Sankhala, Alain C. Mita, Rosie Adinin · 2009 · Journal of Clinical Oncology
136. Balancing Passive and Active Targeting to Different Tumor Compartments Using Riboflavin-Functionalized Polymeric Nanocarriers
     Yoanna Tsvetkova, Nataliia Beztsinna, Maike Baues, Dionne C.G. Klein, Anne Rix, Susanne K. Golombek, Wa’el Al Rawashdeh, Felix Gremse, Matthias Barz, Kaloian Koynov et al. · 2017 · Nano Letters
137. Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt IV prodrug
     Silvia Alonso‐de Castro, Emmanuel Ruggiero, Ane Ruiz‐de‐Angulo · 2017 · Chemical Science
138. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride
     Maolin Guo, Zijian Guo, Peter John Sadler · 2001 · JBIC Journal of Biological Inorganic Chemistry
139. Protein metal-binding sites
     John A. Tainer, Victoria A. Roberts, Elizabeth D. Getzoff · 1992 · Current Opinion in Biotechnology
140. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
     Chunqiu Yu, Zhibin Wang, Zeren Sun, Lei Zhang, Wanwan Zhang, Yungen Xu, Jing‐Jing Zhang · 2020 · Journal of Medicinal Chemistry
141. Copper(II) N,N,O-Chelating Complexes as Potential Anticancer Agents
     Quim Peña, Giuseppe Sciortino, Jean‐Didier Maréchal · 2021 · Inorganic Chemistry
142. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors
     Hink Boer, Johannes H. Proost, Janine Nuver, Sophie Bunskoek, J. Gietema, Barbara M. Geubels, Renske Altena, Nienke R. K. Zwart, Sjoukje F. Oosting, Judith M. Vonk et al. · 2015 · Annals of Oncology
143. Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
     Paul Austin Vasey, R. Atkinson, Robert Edward Coleman, M Crawford, Margaret Eleanor Cruickshank, Peter Eggleton, D Fleming, J Graham, David E. Parkin, James Paul et al. · 2001 · British Journal of Cancer
144. Incorporation of cisplatin into the metal–organic frameworks UiO66-NH 2 and UiO66 – encapsulation vs. conjugation
     Katarzyna A. Mocniak, Ilona Kubajewska, Dominic E. M. Spillane, Gareth R. Williams, Russell E. Morris · 2015 · RSC Advances
145. An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
     Josef Mayr, P. Heffeter, Diana Groza, Luis Galvez, G. Koellensperger, Alexander Roller, Beatrix Alte, Melanie Haider, Walter Berger, C. Kowol et al. · 2016 · Chemical Science
146. CTLA-4 Blockade Expands Infiltrating T Cells and Inhibits Cancer Cell Repopulation during the Intervals of Chemotherapy in Murine Mesothelioma
     Licun Wu, Zhihong Yun, Tetsuzo Tagawa, Katrina Rey‐McIntyre, Marc E. de Perrot · 2012 · Molecular Cancer Therapeutics
147. Ruthenium(II) Polypyridyl Complexes as Photosensitizers for Antibacterial Photodynamic Therapy: A Structure–Activity Study on Clinical Bacterial Strains
     Tony Le Gall, Gilles Lemercier, Sylviane Chevreux · 2018 · ChemMedChem
148. An introduction to the clinical practice of theranostics in oncology
     J. Harvey Turner · 2018 · British Journal of Radiology
149. Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo‐Immunotherapy
     Xiangsheng Liu, Jinhong Jiang, Chong Hyun Chang, Yu‐Pei Liao, Jared J. Lodico, Ivanna Tang, Emily Zheng, Waveley Qiu, Matthew Junda Lin, Xiang Wang et al. · 2021 · Small
150. A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin
     Tiziano Marzo, Luigi Messori · 2020 · ACS Medicinal Chemistry Letters
151. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt IV Complexes under Physiological Conditions
     Alexander Kastner, Isabella Poetsch, Josef Mayr, Jaroslav V. Burda, Alexander Roller, Petra Heffeter, Bernhard K. Keppler, Christian R. Kowol · 2019 · Angewandte Chemie International Edition
152. Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
     Bethany R. Bareham, Nikitas Georgakopoulos, Alba Matas‐Céspedes, Michelle Curran, Kourosh Saeb‐Parsy · 2021 · Cancer Immunology Immunotherapy
153. A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy
     Jing Huang, Yi Zhou, Hong‐Tu Zhang, Tao Qu, Yousheng Mao, Hongxia Zhu, Lanping Quan, Puyuan Xing, Jinwan Wang, Jie He et al. · 2012 · Medical Oncology
154. Liposomes, a promising strategy for clinical application of platinum derivatives
     Sara Zalba, Marı́a J. Garrido · 2013 · Expert Opinion on Drug Delivery
155. Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes
     Adriana Grozav, Ovidiu Bălăcescu, Loredana Bălăcescu, Thomas Cheminel, Ioana Berindan‐Neagoe, Bruno Therrien · 2015 · Journal of Medicinal Chemistry
156. Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
     Philipp Fronik, Isabella Poetsch, Alexander Kastner, Theresa Mendrina, Sonja Hager, Katharina Hohenwallner, Hemma Henrike Schueffl, Dietmar Herndler‐Brandstetter, Gunda Koellensperger, Evelyn Rampler et al. · 2021 · Journal of Medicinal Chemistry
157. Ranitidine bismuth citrate: a novel anti‐ulcer agent with different physico‐chemical characteristics and improved biological activity to a bismuth citrate‐ranitidine admixture.
     A. A. McColm, A McLaren, Graham Klinkert · 1996 · Alimentary Pharmacology & Therapeutics
158. Effective loading of cisplatin into a nanoscale UiO-66 metal–organic framework with preformed defects
     Shi‐Xin Lin, Wei‐Lun Pan, Ru‐Jie Niu, Yan Liu, Jin-Xiang Chen, Wen‐Hua Zhang, Jian‐Ping Lang, David James Young · 2019 · Dalton Transactions
159. A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton
     Hana Kostrhunová, Juraj Zajac, Vojtěch Novohradský, Jana Kašpárková, Jaroslav Malina, Janice Rae Aldrich-Wright, Emanuele Petruzzella, Roman Sirota, Dan Gibson, Viktor Brabec · 2019 · Journal of Medicinal Chemistry
160. Ferrocene‐induced lymphocyte activation and antitumor activity is mediated by redox‐sensitive signaling
     Riva Kovjazin, Tova Eldar, Miriam Patya, Alexey Vanichkin, Harry M. Lander, Abraham Novogrodsky · 2003 · The FASEB Journal
161. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance
     Wantong Song, Zhaohui Tang, Na Shen, Haiyang Yu, Yanjie Jia, Dawei Zhang, Jian Wei Jiang, Chaoliang He, Huayu Tian, Xuesi Chen · 2016 · Journal of Controlled Release
162. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy
     Meixu Chen, Zeqian Huang, Meng Xia, Yaqing Ding, Ting Shan, Zilin Guan, Xiuling Dai, Xiaoyu Xu, Yanjuan Huang, Min Huang et al. · 2021 · Journal of Controlled Release
163. Transgenic Expression of the Human MRP2 Transporter Reduces Cisplatin Accumulation and Nephrotoxicity in Mrp2-Null Mice
     Xia Wen, Brian Buckley, Elizabeth F. McCandlish · 2014 · American Journal Of Pathology
164. A Gallium(III) Complex that Engages Protein Disulfide Isomerase A3 (PDIA3) as an Anticancer Target
     Hao‐Yan Yin, Jiu‐Jiao Gao, Xuemin Chen et al. · 2020 · Angewandte Chemie International Edition
165. Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
     Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Xiao Cheng, Huan Wang, Lisong Teng, Hui Zhou et al. · 2020 · BMC Cancer
166. Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1
     Chaoyun Pan, JiHoon Kang, Jung Seok Hwang, Jie Li, Austin C. Boese, Xu Wang, Likun Yang, Titus J. Boggon, Georgia Z. Chen, Nabil F. Saba et al. · 2021 · Nature Communications
167. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
     Chi‐Hui Tang, Christi L. Parham, Ellyn Shocron, Gerald McMahon, Neela Patel · 2010 · Cancer Chemotherapy and Pharmacology
168. Revisiting the use of sPLA 2 -sensitive liposomes in cancer therapy
     Houman Pourhassan, Gael Clergeaud, Anders E. Hansen, Ragnhild Garborg Østrem, Frederikke P. Fliedner, Fredrik Melander, Ole Lerberg Nielsen, Ciara K. O’Sullivan, Andreas Kjær, Thomas L. Andresen · 2017 · Journal of Controlled Release
169. Tumor targeting using polyamidoamine dendrimer–cisplatin nanoparticles functionalized with diglycolamic acid and herceptin
     Akila Kesavan, Perumal Ilaiyaraja, Winfred Sofi Beaula, Vuttaradhi Veena Kumari, Sugin Lal Jabaris S, C. Arunkumar, G Anjana, Satish Srinivas Kondaveeti, Anita Ramesh, Suresh Kumar Rayala et al. · 2015 · European Journal of Pharmaceutics and Biopharmaceutics
170. An amphiphilic ruthenium(II)–polypyridyl appended porphyrin as potential bifunctional two-photon tumor-imaging and photodynamic therapeutic agent
     Chun‐Ting Poon, Pui‐Shan Chan, Cornelia Man, Feng‐Lei Jiang, Ricky Ngok‐Shun Wong, Naiki K. Mak, Daniel W. J. Kwong, Sai‐Wah Tsao, Wai‐Kwok Wong · 2009 · Journal of Inorganic Biochemistry
171. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
     Claudia S. Schmidt, Tomer Babu, Hana Kostrhunová, Annika Timm, Uttara Basu, Ingo Ott, Valentina Gandin, Viktor Brabec, Dan Gibson · 2021 · Journal of Medicinal Chemistry
172. Trans Titanium(IV) Complexes of Salen Ligands Exhibit High Antitumor Activity
     Avia Tzubery, Edit Y. Tshuva · 2011 · Inorganic Chemistry
173. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo
     Nikolaus Gaßler, C Zhang, Till Wenger · 2005 · British Journal of Cancer
174. One-Pot Synthesis of Mesoporous Silica Nanocarriers with Tunable Particle Sizes and Pendent Carboxylic Groups for Cisplatin Delivery
     Jinlou Gu, Jiapeng Liu, Yongsheng Li, Wenru Zhao, Jianlin Shi · 2012 · Langmuir
175. A brief overview of metal complexes as nuclear imaging agents
     Douglas S. MacPherson, Kimberly Fung, Brendon E. Cook · 2019 · Dalton Transactions
176. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs
     Ida Ritacco, Gloria Mazzone, Nino Russo, Emilia Sicilia · 2016 · Inorganic Chemistry
177. Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes
     Sierra C. Marker, Anna King, Robert V. Swanda · 2020 · Angewandte Chemie International Edition
178. Photodamaging of Mitochondrial DNA to Overcome Cisplatin Resistance by a Ru II –Pt II Bimetallic Complex
     Yue Zheng, Dongyang Zhang, Hang Zhang, Jianjun Cao, Cai‐Ping Tan, Liang‐Nian Ji, Zong‐Wan Mao · 2018 · Chemistry - A European Journal
179. Long-Circulating Thermosensitive Liposomes for the Targeted Drug Delivery of Oxaliplatin
     Ya-Nan Li, Pengcheng Xu, Dongsheng He, Bohui Xu, Jiasheng Tu, Yan Shen · 2020 · International Journal of Nanomedicine
180. Drug transport kinetics of intravascular triggered drug delivery systems
     Timo L.M. ten Hagen, Matthew R. Dreher, Sara Zalba, Ann L.B. Seynhaeve, Mohamadreza Amin, Li Li, Dieter Haemmerich · 2021 · Communications Biology
181. Mortality among Thorotrast-exposed patients and an unexposed comparison group in the German Thorotrast study
     Nikolaus Becker, Dagmar Liebermann, H. Wesch · 2008 · European Journal of Cancer
182. Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade
     Daiko Wakita, TOSHIKI IWAI, Suguru Harada, Miho M. Suzuki, Kaname Yamamoto, Masamichi Sugimoto · 2019 · Anticancer Research
183. Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression
     Taishiro Kishimoto, Yuko Yoshikawa, Kenichi Yoshikawa · 2019 · International Journal of Molecular Sciences
184. Albumin-targeting of an oxaliplatin-releasing platinum( iv ) prodrug results in pronounced anticancer activity due to endocytotic drug uptake in vivo
     Hemma Henrike Schueffl, Sarah Theiner, Gerrit Hermann, Josef Mayr, Philipp Fronik, Diana Groza, Sushilla Schoonhoven, Luis Galvez, Nadine S. Sommerfeld, Arno Schintlmeister et al. · 2021 · Chemical Science
185. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug
     Lili Ma, Na Wang, Rong Ma, Cai Li, Zoufeng Xu, Man‐Kit Tse, Guangyu Zhu · 2018 · Angewandte Chemie
186. Reduction of ormaplatin and cis-diamminetetrachloroplatinum( iv ) by ascorbic acid and dominant thiols in human plasma: kinetic and mechanistic analyses
     Jingran Dong, Yanli Ren, Shuying Huo · 2016 · Dalton Transactions
187. Platinum exposure and cause‐specific mortality among patients with testicular cancer
     Harmke J. Groot, Flora E. van Leeuwen, Sjoukje Lubberts et al. · 2019 · Cancer
188. Gd( iii )–Pt( iv ) theranostic contrast agents for tandem MR imaging and chemotherapy
     Casey J. Adams, Thomas J. Meade · 2020 · Chemical Science
189. Anticancer activity of ruthenium and osmium cyclometalated compounds: identification of ABCB1 and EGFR as resistance mechanisms
     Cynthia Licona, Jean‐Baptiste Delhorme, Gilles Riegel et al. · 2019 · Inorganic Chemistry Frontiers
190. Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells
     Subhendu Karmakar, Hana Kostrhunová, Tereza Ctvrtlikova · 2020 · Journal of Medicinal Chemistry
191. Photocytotoxic cancer cell-targeting platinum( ii ) complexes of glucose-appended curcumin and biotinylated 1,10-phenanthroline
     Aarti Upadhyay, Srishti Gautam, Vanitha Ramu, Paturu Kondaiah, Akhil Ranjan Chakravarty · 2019 · Dalton Transactions
192. Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)
     Bei Xu, Min Zeng, Jiawei Zeng · 2018 · Medicine
193. Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis
     Ananda Mookerjee, Jayati Mookerjee Basu, Pranabananda Dutta, Surajit Majumder, Sankar Bhattacharyya, Jaydip Biswas, Smarajit Pal, Pratima Mukherjee, Sanghamitra Raha, Rathindra Nath Baral et al. · 2006 · Clinical Cancer Research
194. Early phago-/endosomal escape of platinum drugs via ROS-responsive micelles for dual cancer chemo/immunotherapy
     Pei‐Wei Shueng, Lu-Yi Yu, Hsin‐Cheng Chiu, Hui-Ching Chang, Yen‐Ling Chiu, Tzu-Yu Kuo, Yu-Wei Yen, Chun-Liang Lo · 2021 · Biomaterials
195. Copper: Inorganic & Coordination ChemistryBased in part on the article Copper: Inorganic & Coordination Chemistry by Rebecca R. Conry & Kenneth D. Karlin which appeared in the Encyclopedia of Inorganic Chemistry, First Edition .
     Rebecca R. Conry · 2005 · Encyclopedia of Inorganic Chemistry
196. Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer
     Vivek Patel, Rohan Lalani, Imran Vhora · 2020 · Drug Delivery and Translational Research
197. A cross-linked polymeric micellar delivery system for cisplatin(IV) complex
     Haiqin Song, Rui Wang, Haihua Xiao, Haidong Cai, Wenjing Zhang, Zhigang Xie, Yubin Huang, Xiabin Jing, Tongjun Liu · 2012 · European Journal of Pharmaceutics and Biopharmaceutics
198. A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer
     Jerome Dallas Winegarden, Ann M. Mauer, Gregory A. Otterson · 2004 · Annals of Oncology
199. Heterogeneity of Regional Redox Status and Relation of the Redox Status to Oxygenation in a Tumor Model, Evaluated Using Electron Paramagnetic Resonance Imaging
     Keizo Takeshita, Kumiko Kawaguchi, Kaori Fujii-Aikawa · 2010 · Cancer Research
200. Cisplatin-Encapsulated Polymeric Nanoparticles with Molecular Geometry-Regulated Colloidal Properties and Controlled Drug Release
     Yun-Ho Jeong, Hyeon-Woo Shin, Ji-Yeong Kwon, Sang‐Min Lee · 2018 · ACS Applied Materials & Interfaces